Fundraising Fox

Beam Therapeutics

NASDAQ: BEAM

Cambridge, US · Founded 2017 · Delaware corporation · 8 known investors

beamtx.com ↗

Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases. The company works across multiple therapeutic areas to advance precision medicine treatments at the molecular level.

BiotechDeep TechMedical Devicesin /beamtx@BeamTx

Founders & leadership

DRDavid R. Liu
David R. LiuFounder and Inventor
JKJ. Keith Joung
J. Keith JoungFounder and Inventor
FZFeng Zhang
Feng ZhangFounder and Inventor
CH
CAROLE HODirector
JEJohn Evans
John EvansExecutive Officer, Director
MFMARK FISHMAN
MARK FISHMANDirector
MY
MICHAEL YIDirector
SK
STEPHEN KNIGHTDirector
KB
KRISTINA BUROWDirector
RN
ROBERT NELSENDirector

Investors · 8

ARCH Venture PartnersChicago · $50K – $250M
Dreamers VCEl Segundo · $500K – $5M
Eight Roads VenturesBangalore · $5M – $30M
F-Prime Capital PartnersCambridge · $3M – $10M
Foresite CapitalLarkspur
GV (Google Ventures)Mountain View · $250K – $50M
HongShan Capital GroupHong Kong
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M

Reported raises · per SEC filings

Form D private placements
▶$83.6MraisedMar 2019 · 21 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • KRISTINA BUROWDirector
  • MICHAEL YIDirector
  • CAROLE HODirector
  • STEPHEN KNIGHTDirector
  • JOHN EVANSExecutive Officer, Director
  • MARK FISHMANDirector
  • ROBERT NELSENDirector
Offering amount
$83.6M
Amount sold
$83.6M
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$135MraisedMar 2019 · 27 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • CAROLE HODirector
  • STEPHEN KNIGHTDirector
  • KRISTINA BUROWDirector
  • JOHN EVANSExecutive Officer, Director
  • MARK FISHMANDirector
  • MICHAEL YIDirector
  • ROBERT NELSENDirector
Offering amount
$135M
Amount sold
$135M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news